Vaccination and immunization

How can you protect yourself against respiratory infections?

Respiratory infections: prepare today for protection tomorrow

This campaign is an initiative of Pfizer.


Respiratory infections are often associated with winter. However, while some are seasonal, others can occur at any time of the year and may lead to serious complications, hospitalizations, or even death. Fortunately, there is a simple and effective way to help protect yourself: vaccination.¹ Talk to your general practitioner, who can advise you based on your individual profile.

Which infections – and why get vaccinated?

Certain viral or bacterial infections can affect the respiratory tract down to the lungs and become severe, particularly in people with a weakened immune system.

These are the main infections that deserve special attention:

Influenza remains a well-known threat. Although it mainly occurs during the colder months, the impact of flu remains unpredictable. Each year, an average of 500,000 people in Belgium are affected, and more than 90% of deaths occur in people aged 65 and over. Thankfully, an adapted vaccine is available every season. ²


Pneumococcal infections are a major cause of severe pneumonia. In 2024, Belgium recorded a significant increase in pneumococcal infections, with more than 2,000 reported cases. ³ This trend continued during the first half of 2025, with a total of 1,631 reported cases between 1 January 2025 and 30 June 2025. This represents an increase of 38.7% compared to the same period in 2024. ⁴ Among people aged 65 and over, the mortality rate is 12% and doubles in those aged 85 and over.⁵ Vaccination can help reduce the risk of developing pneumococcal pneumonia. ⁶


Whooping cough was long mistakenly considered a childhood disease, but it can be severe at any age. Today, up to five babies still die from whooping cough every year in Belgium. ⁷ Pregnant women and older adults are particularly at increased risk. Due to the recent resurgence, booster vaccinations are important, especially to protect young infants who are not or only partially vaccinated, as well as vulnerable adults. ⁷˒⁸


RSV infections (respiratory syncytial virus) are common in babies, but adults can also be infected. Around 7,000 cases are identified each year in Belgium. ⁹ The virus can lead to complications such as bronchiolitis or pneumonia. ¹⁰ Among hospitalised adults, 58% develop at least one complication. ¹¹ For these at-risk groups, targeted vaccination is now available. Infants can also be protected from birth, either through vaccination of the mother during pregnancy or through the injection of monoclonal antibodies in the first days of life.


Although Covid-19 is now better controlled, it remains a significant respiratory infection. In 2024, it accounted for 41% of seasonal respiratory infections in Belgium. ¹² Less than half of people aged 65 and over were vaccinated at that time, even though the risk of death among hospitalized patients remains higher than for influenza. ¹³˒¹⁴ Annual vaccination therefore continues to be strongly recommended for the most vulnerable individuals.

Who should be vaccinated first?

Some people are at greater risk of developing severe forms of respiratory infections. It is essential to prioritize their protection:


  • People aged over 60 years¹⁵-¹⁷
  • People with chronic conditions (such as cancer, diabetes, asthma, heart or lung disease, kidney failure, etc.) ⁷˒¹⁵-¹⁷
  • Pregnant women¹⁷-¹⁸
  • Babies and young children¹⁷-²⁰

In practice

Vaccination is an effective way to protect yourself and those around you against preventable diseases. ¹ Some vaccines can be administered at the same time and, in some cases, in certain pharmacies. Do not wait until winter to protect yourself — plan your vaccinations, or those of your loved ones, in good time. It is a simple step to avoid many complications.


260090 – April 2026


Have a question? Ask our specialists

Ask anonymously Ask for free

Ask our specialists

We’ll email you here as soon as a specialist answers your question

QnA guideline for submitting question

Provide context and detail about your health concerns
Be short and to the point so specialists can give you a clear answer
Avoid offensive or abusive content, as well as name references
Do not ask about prices, prescriptions, or diagnoses
Submit your question
We’ll email you here when there is an answer
We got your question

We’ll email you when a specialist replies.

We couldn’t submit your question

An unexpected error occurred but we’re working on it. Please try again.

If you need a more thorough and clear opinion or solution on a health issue, the best you can do is visit a specialist. In doctoranytime you can find specialized doctors or health professionals for your needs. You are already in good hands!

FIND A DOCTOR
Resources

1. World Health Organization. Vaccines and immunization: What is vaccination? WHO, 2024, https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-what-is-vaccination

2. https://www.sciensano.be/en/node/464.. Accessed April 2026

3. National Reference Center for invasive S. pneumoniae, UZ Leuven; Communication January 2025: Exceptional high number of invasive pneumococcal isolates for (December) 2024. Centre National de Référence (CNR) pour Streptococcus pneumoniae (invasive) | sciensano.be.

4. https://www.sciensano.be/sites/default/files/report_nrc_srpn_2025_first_half.pdf. Accessed April 2026

5. PIXS SRL (2024). La vaccination contre le pneumocoque chez l’adulte. [online] Promo Santé & Médecine Générale. https://promosante.be/vaccination-contre-pneumocoque-adulte-fiche-informative-pour-medecins-generalistes. (Available in French only). Accessed April 2026

6. Superior Health Council (of Belgium). Vaccination against RSV (adults). Brussels: SHC; 2024. Report No. 9837.

7. Dr. Sandrine Milas. La coqueluche en Belgique : épidémiologie et adaptation de la stratégie vaccinale pour la protection des nourrissons. NOSO INFO - Bulletin pour la prévention et la maîtrise des infections associées au soins, 2024. https://www.nosoinfo.be/nosoinfos/la-coqueluche-en-belgique-epidemiologie-et-adaptation-de-la-strategie-vaccinale-pour-la-protection-des-nourrissons-2. (Available in French only). Accessed April 2026

8. http://https://www.pasteur.fr/fr/centre-medical/fiches-maladies/coqueluche (Available in French only). Accessed April 2026

9. https://www.sciensano.be/en/health-topics/respiratory-syncytial-virus-rsv/numbers#rsv-infection-in-belgium. Accessed April 2026

10. https://www.gfcni.org/fileadmin/www.gfcni.org/Campaigns/RSV_All_Infants/Parent_Booklet/English/2025_GFCNI_RSV_Parentbooklet_6thEdition_EN_web.pdf. Accessed April 2026.

11. Descamps A, et al. In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017–2019: an observational study. Eur Respir J. 2022;59(3):2100651.

12. Research on respiratory diseases conducted in November 2024 by the independent market research agency Buffl, commissioned by Pfizer. The sample consisted of 1,000 respondents, with a margin of error of 3%, and was representative in terms of language, gender, age, level of education and household composition.

13. https://epidata.sciensano.be/epistat/dashboard/#covid_vaccination - Accessed April 2026.

14. Xie Y, Choi T, Al-Aly Z. Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024. JAMA. 2024;331(22):1963-1965. , https://doi.org/10.1001/jama.2024.7395

15. Superior Health Council (of Belgium). Vaccination against RSV (adults). Brussels: SHC; 2024. Report No. 9837.

16. Superior Health Council (of Belgium). COVID-19 - Belgian vaccination strategy - 2025-2026. Brussels: SHC; 2025. Report No. 9880.

17. Superior Health Council (of Belgium). Vaccination against Seasonal Influenza 2026 - 2027. Brussels: SHC; 2026. Report No. 9897.

18. Superior Health Council (of Belgium). Maternal immunisation: Belgian guidelines. Brussels: SHC; 2020. Report No. 8754.

19. Superior Health Council (of Belgium). Preventive strategies against RSV disease in children. Brussels: SHC; 2023. Report No. 9760.

20. Hoge Gezondheidsraad. Vaccinatie tegen difterie, tetanus en kinkhoest bij kinderen. Brussel: HGR; 2013. Advies n° 8807. (Available in Dutch & French only)

This page does not contain medical advice.
This page does not contain promotional content nor advertisements.
Note: The term "doctor" is used for brevity and may include health professionals too.
This content is reliable and scientifically documented. It is based on official medical studies and it is edited by doctors and health professionals and shows objective information on diagnosis and treatment of diseases. It includes resources. If you are a health professional and you found out errors or omissions, please contact us on [email protected]
Thank you!

Your experience can be very helpful to others

Join doctoranytime for free by clicking here.

Something went wrong

Try again later

Your feedback was submitted

Tell us how we can improve it.